It’s been two and a half years since Emma Walmsley took over as CEO of GlaxoSmithKline ... with perhaps the most eye-catching appointment being that of chief scientific officer Hal Barron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback